UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - SUCAMPO PHARMACEUTICALS INC ownership

SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 4 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SUCAMPO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$191,526,000
+118125.9%
10,670
-18.9%
0.00%
Q3 2016$162,000
+12.5%
13,1590.0%0.00%
Q2 2016$144,00013,1590.00%
Other shareholders
SUCAMPO PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,304,376$23,414,0007.30%
Kassirer Asset Management Corp 291,784$5,238,0005.39%
First Trust Capital Management L.P. 637,578$11,445,0002.19%
NEXTHERA CAPITAL LP 510,486$9,163,0001.69%
HAVENS ADVISORS LLC 100,000$1,795,0001.35%
Piermont Capital Management Inc. 172,980$3,105,0001.02%
PRELUDE CAPITAL MANAGEMENT, LLC 674,446$12,106,0000.97%
ALPINE ASSOCIATES MANAGEMENT INC. 1,495,600$26,845,0000.96%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 200,000$3,590,0000.87%
BOOTHBAY FUND MANAGEMENT, LLC 332,075$5,961,0000.87%
View complete list of SUCAMPO PHARMACEUTICALS INC shareholders